ICU Medical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 245.07 M

ICU Medical, Inc. EBITDA is USD 245.07 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -47.98% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • ICU Medical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 471.07 M, a 70.33% change year over year.
  • ICU Medical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 276.56 M, a 46.50% change year over year.
  • ICU Medical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 188.77 M, a -5.46% change year over year.
  • ICU Medical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 199.68 M, a 4.18% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)